spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  Theratechnologies 

 HSMN NewsFeed - 2 Mar 2020
Change to Theratechnologies Management
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Jul 2018
Theratechnologies Submits Novel Single-Vial Formulation of EGRIFTA(R) (Tesamorelin for Injection) for FDA Approval
Biopharmaceuticals HIV/AIDS FDA
 HSMN NewsFeed - 13 Dec 2013
Theratechnologies Regains U.S. Marketing Rights to EGRIFTA(R)
Biopharmaceuticals Licensing
 HSMN NewsFeed - 22 Jun 2012
Theratechnologies Provides Regulatory Update on Tesamorelin
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 3 Feb 2011
Theratechnologies and Ferrer Announce a Distribution & Licensing Agreement for Tesamorelin in Europe
Biopharmaceuticals Licensing Distribution
 HSMN NewsFeed - 1 Dec 2010
Theratechnologies Welcomes the Arrival of Its New President and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Nov 2010
FDA Approves EGRIFTA(TM) (Tesamorelin for Injection): The First and Only Treatment for the Reduction of Excess Abdominal Fat in HIV-Infected Patients With Lipodystrophy
Biopharmaceuticals FDA
 HSMN NewsFeed - 18 Jan 2010
Theratechnologies Reports Date for FDA Advisory Committee Review of the Tesamorelin New Drug Application
Biopharmaceuticals HIV/AIDS FDA
 HSMN NewsFeed - 29 Oct 2008
EMD Serono and Theratechnologies Announce Collaboration and Licensing Agreement for Tesamorelin in the United States
Biopharmaceuticals Licensing
 HSMN NewsFeed - 1 Oct 2007
Theratechnologies Reports Positive 52-Week Phase 3 Results for its Lead Drug Candidate Tesamorelin
Biopharmaceuticals HIV/AIDS
 HSMN NewsFeed - 9 Aug 2007
Theratechnologies Appoints Dr. Pierre Caudrelier as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Jan 2007
Theratechnologies Launches Confirmatory Phase 3 Trial Testing TH9507 in HIV-Associated Lipodystrophy
Biopharmaceuticals
 HSMN NewsFeed - 25 Oct 2006
Theratechnologies: Last Patient Treated in Pivotal TH9507 Trial
Biopharmaceuticals
Return to NewsFeed  

 Additional items found! 9

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 9 additional stories matching:
Theratechnologies
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!